The Recall Desk

FDA (Drugs) recall action 70515

Hospira Inc. recalled 2 products on 2015-04-15

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2015-04-15
Critical
0
Units
—

Why these products were recalled

Crystallization

The agency’s own wording, quoted from the enforcement report.

1–2 of 2

  • HighFDA (Drugs)··2015-04-15

    Hospira Recalls Ketorolac Tromethamine Injection Due to Crystallization

    Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection because of crystallization. The affected vials were distributed nationwide and in Guam and Singapore.

    Product
    KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2015-04-15

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection due to crystallization. The recall covers vials distributed nationwide and internationally.

    Product
    KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Distribution
    0 states
Hospira Inc. recalled 2 products on 2015-04-15 · The Recall Desk